RxDoctor Payments Data

Paul Tortolani, MD

Orthopaedic Surgery · Towson, MDNPI 1174545602

Payments from drug & device makers

What this record shows

The money is spread across several categories — royalties or licence payments (59.5%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Innovasis Inc accounts for 67.7% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2019 at $147,524 and has fallen 53.2% since, to $69,009 in 2025. Among orthopaedic surgery clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$812,140in general payments, 2019–2025

Across 194 payments — averaging $4186.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Innovasis Inc$550K
  • Globus Medical$245K
  • Highridge Medical LLC$9K
  • Stryker$2K
  • Supreme Orthopedic Systems, LLC$2K
  • Arthrex$2K
  • plus $2K from 11 others
$16,100in research payments, 2019–2025

Across 1 payment — averaging $16,100 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Spineology Inc.$16K

What the payments were for

  • Royalty or licence$483,48660%
  • Consulting fees$311,20938%
  • Travel & lodging$12,8102%
  • Food & beverage$4,6341%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$812,140 in reported general payments places this provider in the 95th percentile of 378 orthopaedic surgery providers in Maryland.

See all orthopaedic surgery providers in Maryland

Medicare billing

Part B allowed, 2024
$669,345
Medicare patients
678
Services billed
2,220

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mupirocin65$481

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Towson

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →